Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer
NCT02074189Phase 3Unknown
- Sponsor
- Southwest Health System
- Start
- Mar 2014
- Primary completion
- Apr 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, Cisplatin micelle injection (HA132) in bladder cancer, sponsored by Southwest Health System. Status: unknown.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02074189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074189.